DEUTSCHE BANK AG\ - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 41 filers reported holding CLEVELAND BIOLABS INC in Q4 2013. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q3 2013$060.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q4 2013
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,826,158$1,244,0000.07%
LADENBURG THALMANN FINANCIAL SERVICES INC. 721,200$507,0000.02%
Winfield Associates, Inc. 15,711$11,0000.01%
Van Cleef Asset Management,Inc 20,000$14,0000.01%
ACG Wealth 25,000$17,0000.01%
TAURUS ASSET MANAGEMENT, LLC 15,000$10,0000.00%
OPPENHEIMER & CO INC 25,500$17,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 500$341,0000.00%
BANK OF AMERICA CORP /DE/ 5,390$4,0000.00%
WELLS FARGO & COMPANY/MN 3,000$2,0000.00%
View complete list of CLEVELAND BIOLABS INC shareholders